Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LPAR3 | Q9UBY5 | 10/20 | 0.68 |
| ▸ | LPAR2 | Q9HBW0 | 8/20 | 0.68 |
| ▸ | LPAR1 | Q92633 | 5/20 | 0.68 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.61 |
| ▸ | FAAH | O00519 | 2/20 | 0.52 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21439794 | 1.00 | LPAR3 (0.68) | LPAR3LPAR2LPAR1CYP3A4FAAH | |
| SCHEMBL28522407 | 1.00 | LPAR3 (0.68) | LPAR3LPAR2LPAR1CYP3A4FAAH | |
| SCHEMBL304774 | 1.00 | LPAR3 (0.68) | LPAR3LPAR2LPAR1CYP3A4FAAH | |
| SCHEMBL21439796 | 1.00 | LPAR3 (0.68) | LPAR3LPAR2LPAR1CYP3A4FAAH | |
| SCHEMBL6119544 | 1.00 | LPAR3 (0.68) | LPAR3LPAR2LPAR1CYP3A4FAAH | |
| SCHEMBL7800702 | 1.00 | LPAR3 (0.68) | LPAR3LPAR2LPAR1CYP3A4FAAH | |
| SCHEMBL4981336 | 1.00 | LPAR3 (0.68) | LPAR3LPAR2LPAR1CYP3A4FAAH | |
| SCHEMBL8736972 | 0.94 | LPAR3 (0.62) | LPAR3LPAR2LPAR1CYP3A4FAAH | |
| Ammonia Solution, Strong SCHEMBL29013109 | 0.93 | LPAR3 (0.62) | LPAR3LPAR2LPAR1CYP3A4FAAH | |
| SCHEMBL11360949 | 0.91 | LPAR3 (0.63) | LPAR3LPAR2LPAR1CYP3A4TRPV1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 88 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240009092-A1 | COSMETIC COMPOSITION AND COSMETIC QUASI-DRUG INCLUDING LIPID PARTICLES CONTAINING PHOSPHOLIPID | NIPPON SHOKUBAI CO., LTD. (JP) | 2024-01-11 | — | — | US | disclosed |
| US-20230390165-A1 | POWDERY SOLID COSMETIC | SHISEIDO COMPANY, LTD. (JP) | 2023-12-07 | — | — | US | disclosed |
| US-11696886-B2 | Cosmetic | SHISEIDO COMPANY, LTD. (JP) | 2023-07-11 | — | — | US | disclosed |
| US-11529293-B2 | Oil-in-water emulsion cosmetic | SHISEIDO COMPANY, LTD. (JP) | 2022-12-20 | — | — | US | disclosed |
| CN-114514013-A | Cosmetic preparation | 株式会社资生堂 | 2022-05-17 | — | — | CN | disclosed |
| US-20220001443-A1 | POWDER DISPERSION COMPOSITION AND DISPERSING METHOD THEREOF | SHISEIDO COMPANY, LTD. (JP) | 2022-01-06 | — | — | US | disclosed |
| US-20220000758-A1 | COSMETIC | SHISEIDO COMPANY, LTD. (JP) | 2022-01-06 | — | — | US | disclosed |
| EP-3881899-A1 | COSMETIC | Shiseido Company, Ltd. (JP) | 2021-09-22 | — | — | EP | disclosed |
| EP-3881820-A1 | POWDER DISPERSION COMPOSITION AND DISPERSING METHOD THEREOF | Shiseido Company, Ltd. (JP) | 2021-09-22 | — | — | EP | disclosed |
| US-20210128445-A1 | COSMETIC | SHISEIDO COMPANY, LTD. (JP) | 2021-05-06 | — | — | US | disclosed |
| EP-1153595-A2 | Clear aqueous ceramide composition | Takasago International Corporation (JP) | 2001-11-14 | — | — | EP | disclosed |
| EP-1036553-A2 | Solid water-in-oil type emulsion cosmetic composition | SHISEIDO COMPANY LIMITED (JP) | 2000-09-20 | — | — | EP | disclosed |
| EP-0972508-A1 | EXTRACELLULAR MATRIX PRODUCTION PROMOTER | SHISEIDO COMPANY LIMITED (JP) | 2000-01-19 | — | — | EP | disclosed |
| EP-0900561-A1 | COMPOSITIONS PROMOTING COLLAGEN PRODUCTION | SHISEIDO COMPANY LIMITED (JP) | 1999-03-10 | — | — | EP | disclosed |
| US-5853705-A | Anti-aging cosmetic composition | SHISEIDO COMPANY, LTD. (JP) | 1998-12-29 | — | — | US | disclosed |
| EP-0852949-A2 | Use of alpha-amino-acids for enhancing desmosomal degradation or stratum corneum desquamation | SHISEIDO COMPANY LIMITED (JP) | 1998-07-15 | — | — | EP | disclosed |
| EP-0815838-A2 | External skin treatment composition | SHISEIDO COMPANY, LTD. (JP) | 1998-01-07 | — | — | EP | disclosed |
| EP-0797984-A2 | Anti-aging cosmetic composition | SHISEIDO COMPANY LIMITED (JP) | 1997-10-01 | — | — | EP | disclosed |
| EP-0487404-B1 | External dermatological composition | HAYASHIBARA BIOCHEM LAB (JP) | 1995-10-11 | — | — | EP | disclosed |
| EP-0487404-A1 | External dermatological composition | KABUSHIKI KAISHA HAYASHIBARA SEIBUTSU KAGAKU KENKYUJO (JP) | 1992-05-27 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220000758-A1 | COSMETIC | CUTA, SQLE, FDFT1 | LPAR3 1430/4885LPAR2 2204/4885LPAR1 1491/4885 |
| US-20240009092-A1 | COSMETIC COMPOSITION AND COSMETIC QUASI-DRUG INCLUDING LIPID PARTICLES CONTAINING PHOSPHOLIPID | PLIN5, PHOSPHO1, PLIN3 | LPAR3 33/4885LPAR2 32/4885LPAR1 24/4885 |
| US-11529293-B2 | Oil-in-water emulsion cosmetic | CUTA, TYR, LPO | LPAR3 1012/4885LPAR2 2309/4885LPAR1 1218/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.